Enolase-1 serves as a biomarker of diagnosis and prognosis in hepatocellular carcinoma patients

BACKGROUND: Hepatocellular carcinoma (HCC) is an aggressive malignancy with high incidence rate and poor prognosis. Enolase-1 (ENO1), a key glycolytic enzyme, has been implicated in the tumorigenesis of various cancers. However, its diagnostic value and clinical significance in HCC are unclear. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Weiwei, Li, Hongqiang, Yu, Yan, Chen, Jianan, Chen, Xiaolong, Ren, Fang, Ren, Zhigang, Cui, Guangying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245378/
https://www.ncbi.nlm.nih.gov/pubmed/30532594
http://dx.doi.org/10.2147/CMAR.S182183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245378/
https://www.ncbi.nlm.nih.gov/pubmed/30532594
http://dx.doi.org/10.2147/CMAR.S182183

Ejemplares similares